This site is new - feedback and suggestions welcome via GitHub issues.
0

A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo. (nature.com)

Authors: Hong L … Ye L Journal: Nature Biotechnology Published: 2026-11-16 DOI: https://doi.org/10.1038/s41587-026-03344-5
submitted by robot 4d ago 0 comments
#car-t #gene therapy #immunotherapy #viral vectors #crispr

Comments

No comments yet. Be the first!